$31 Million Doximity Securities Fraud Settlement, Did You Buy DOCS Stock Between 2021 and 2023?

Investors who bought Doximity stock between June 24, 2021 and August 8, 2023 may be owed money from a $31 million class action settlement. The lawsuit accuses Doximity and its CEO of lying to investors about how many doctors were actively using the platform. The court granted preliminary approval on February 25, 2026. You must file your claim by July 16, 2026 to receive any payment.

Field	Detail
Settlement Amount	$31,000,000
Claim Deadline	July 16, 2026
Who Qualifies	Anyone who purchased or acquired Doximity (DOCS) common stock from June 24, 2021 through August 8, 2023
Payout Per Person	Estimated ~$0.32 per share (pro rata; final amount TBD)
Proof Required	Yes — trading records required
Settlement Status	Preliminarily approved
Administrator	AB Data, Ltd.
Official Website	DoximitySecuritiesLitigation.com

Where things stand right now:

• The court granted preliminary approval on February 25, 2026. Final approval is scheduled for a hearing on June 10, 2026 at 9:00 a.m. Pacific Time.
• The deadline to object or opt out of the settlement is May 20, 2026.
• Payments will go out only after the court grants final approval and all appeals are resolved — no payment date has been confirmed yet.

How Doximity Allegedly Misled the Investors Who Trusted It

Doximity calls itself the “LinkedIn for doctors.” The platform lets U.S. physicians access medical news, telehealth tools, and pharmaceutical advertisements — all for free. Because Doximity charges nothing to its physician members, it earns more than 90% of its revenue from pharmaceutical companies that pay to advertise on the platform.

That advertising model only works if drugmakers believe Doximity’s doctors are actually logging in and engaging. So Doximity aggressively marketed its engagement numbers to both advertisers and investors. Starting on the day it went public — June 24, 2021 — CEO Jeffrey Tangney told CNBC that “over 80% of all U.S. physicians” were active members on the platform. He repeated that claim twice in the same televised interview. Doximity’s stock doubled that day, pushing its market cap above $9 billion.

The lawsuit, filed in federal court in the Northern District of California, alleges those “active member” figures were false. According to the complaint, Doximity’s actual base of active physicians was far lower than 80%, and engagement — particularly on the ad-driven Newsfeed — was not growing but falling. Investors allegedly had no way to know this because Doximity never disclosed the real numbers during the class period.

You Were in This Class If You Held DOCS Stock During This Window

You may qualify for a payment if:

• You purchased or otherwise acquired Doximity, Inc. (NYSE: DOCS) common stock at any point from June 24, 2021 through August 8, 2023, inclusive.
• You suffered financial losses as a result of holding that stock during the class period.
• You are not excluded from the settlement class by definition (Doximity, its officers and directors, and certain related parties are excluded — see paragraph 32 of the official Notice for the full list).
• You have not already opted out of the Settlement Class in writing before the May 20, 2026 deadline.

Institutional investors — pension funds, mutual funds, and asset managers — may file electronically through the settlement website’s dedicated institutional filing portal.

The $31 Million Gets Divided — Here Is What Your Share Could Look Like

The $31,000,000 settlement fund will be distributed on a pro rata basis among all valid claimants. Bloomberg Law reported an estimated average recovery of approximately $0.32 per damaged share. That figure is an estimate only — your actual payment depends on how many eligible claimants file and how the plan of allocation values your specific trades.

Related article: Weber Recalled 3.2 Million Grill Brushes Now It Faces a Class Action Over What It Didn’t Tell You

Attorneys’ fees, litigation expenses, and claims administration costs will be deducted from the $31 million before any distributions go out. The court will rule on those deductions at the June 10, 2026 hearing. Final individual payout amounts are TBD until all claims are processed and appeals (if any) are resolved.

Four Steps to File Your Doximity Settlement Claim Before July 16, 2026

Step 1 — Go to the official settlement website: DoximitySecuritiesLitigation.com

Step 2 — Download the Claim Form PDF or click “File Online Claim Form” to submit electronically.

Step 3 — Enter your personal information and your complete trading history for Doximity stock (purchases and sales) between June 24, 2021 and August 8, 2023. You will need your brokerage statements or trade confirmations.

Step 4 — Submit your completed Claim Form online or mail it postmarked no later than July 16, 2026 to the address listed in the Notice. Save your confirmation number or mailing receipt.

Estimated time to complete: 10–20 minutes if you have your brokerage records ready.

Questions? Call the Doximity Securities Litigation Help Line at 1-800-254-2939 or email [email protected].

Every Key Date Between the IPO Lie and Your Payment

Milestone	Date
Class Period Begins (IPO Day)	June 24, 2021
Class Period Ends (Guidance Cut Disclosed)	August 8, 2023
Initial Complaint Filed	April 17, 2024
Lead Plaintiff Appointed	July 3, 2024
Consolidated Complaint Filed	October 4, 2024
Motion to Dismiss Denied	May 13, 2025
Settlement Agreement Signed	December 24, 2025
Preliminary Approval Granted	February 25, 2026
Claims Period Opens	February 25, 2026
Opt-Out / Objection Deadline	May 20, 2026
Final Approval Hearing	June 10, 2026
Claim Filing Deadline	July 16, 2026
Expected Payment Date	TBD (after final approval and appeals)

Frequently Asked Questions

Do I need a lawyer to file a claim?

 No. Any eligible investor can file a claim directly at DoximitySecuritiesLitigation.com without hiring an attorney. The process is straightforward — you enter your personal details and upload your trading records. Filing is free, and you keep your full share of any payment.

Is this settlement legitimate? 

Yes. The U.S. District Court for the Northern District of California — a federal court — granted preliminary approval on February 25, 2026. The settlement administrator is AB Data, Ltd., a well-established class action administrator. The official case number is 5:24-cv-02281-NW. Always file through the official settlement website only: DoximitySecuritiesLitigation.com.

When will I receive my payment? 

No payment date has been confirmed. Payments go out only after the court grants final approval at the June 10, 2026 hearing, all appeals are resolved, and all claims are processed. Realistically, that process can take many months to over a year after final approval.

What if I miss the July 16, 2026 claim deadline? 

If you do not submit your Claim Form by July 16, 2026, you will not receive any payment from the settlement — even if you are otherwise eligible. You will still be bound by the settlement and give up your right to sue Doximity separately over the same claims.

Will this settlement payment affect my taxes? 

Possibly. Settlement payments related to investment losses may have tax implications depending on your individual situation. The settlement notice does not address tax treatment. Consult a qualified tax professional before filing your taxes for the year you receive any payment.

I held Doximity stock in a retirement account — can I still file?

 Yes. The settlement covers all purchases or acquisitions of Doximity common stock during the class period regardless of what type of account you held the shares in. Gather your brokerage or plan statements showing the trades and file as normal.

Why did Doximity’s stock crash in August 2023? 

On August 8, 2023, Doximity cut its revenue guidance for fiscal year 2024. On the earnings call, executives acknowledged that advertisers were shifting their budgets to cheaper banner ads on other social platforms — signaling that pharmaceutical companies no longer believed Doximity could deliver the engaged physician audience it had promised. The stock dropped nearly 23% in a single day, erasing more than $900 million in shareholder value.

What exactly was the “active member” claim that started this lawsuit?

 From the day of its IPO, Doximity — and CEO Jeffrey Tangney specifically — repeatedly told investors that “over 80% of all U.S. physicians” were active members on the platform. The lawsuit alleges that figure was materially false, that real active membership was far below that threshold, and that Doximity concealed declining engagement on the revenue-generating Newsfeed throughout the class period.

Sources

• Official Settlement Website: DoximitySecuritiesLitigation.com
• BLB&G Case Page: blbglaw.com/cases-investigations/doximity-securities-litigation
• Court Docket: U.S. District Court, N.D. California, Case No. 5:24-cv-02281-NW (via PACER)
• Bloomberg Law: “Doximity Will Pay $31 Million to End Shareholder Suit,” January 5, 2026

Last Updated: April 2, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.